Centro Integrado de Protótipos, Biofármacos e Reativos para Diagnóstico, Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fiocruz, Rio de Janeiro, RJ, 21040-360, Brazil,
Cytotechnology. 2015 Mar;67(2):331-42. doi: 10.1007/s10616-014-9689-0. Epub 2014 Jun 27.
The baculovirus Anticarsia gemmatalis nucleopolyhedrovirus (AgMNPV), a member of the family Baculoviridae, has been widely applied as a biopesticide for the control of the velvetbean caterpillar, a pest of soybean crop field. Baculoviruses are considered safe and efficient agents for this purpose, because they do not infect vertebrates, being safe for the health of humans and animals, as well as to the environment. The objective of this work was to identify proteins obtained from Lonomia obliqua hemolymph with potential application in the optimization of baculovirus AgMNPV replication in Sf9 insect cell culture. In this work the improvement of the cell culture and viral replication of the AgMNPV baculovirus was observed when Grace medium was supplemented with 10 % (v/v) Fetal Bovine Serum (FBS), 1 % (v/v) hemolymph extract, or 3 % (v/v) of hemolymph fractions or hemolymph sub-fractions obtained by purifying hemolymph through High Performance Liquid Chromatography. Hemolymph presented a positive effect on the synthesis of polyhedra and enhanced baculovirus replication in Spodoptera frugiperda (Sf9) cells (TCID50/mL), and led to Sf9 cell culture improvement. Grace medium supplemented with 10 % (v/v) FBS and 1 % (v/v) hemolymph provided an increase of baculovirus replication, when the cells were infected with multiplicity of infection of 1. In this case, the baculovirus replication was 6,443.91 times greater than that obtained with the control: Grace medium supplemented with 10 % (v/v) FBS. In addition, this work suggests that hemolymph from L. obliqua could have an interesting application in biotechnology, due to an increase in the viability of the cells and virus replication.
杆状病毒 Anticarsia gemmatalis 核多角体病毒(AgMNPV)是杆状病毒科的一员,已被广泛用作生物农药来控制大豆田的棉铃象甲害虫。杆状病毒被认为是安全有效的制剂,因为它们不会感染脊椎动物,对人类和动物的健康以及环境都是安全的。本工作的目的是从南美大蚕蛾的血淋巴中鉴定出具有潜在应用价值的蛋白质,以优化杆状病毒 AgMNPV 在 Sf9 昆虫细胞培养中的复制。在这项工作中,当 Grace 培养基中补充 10%(v/v)胎牛血清(FBS)、1%(v/v)血淋巴提取物或 3%(v/v)通过高效液相色谱法纯化血淋巴获得的血淋巴级分或亚级分时,AgMNPV 杆状病毒的细胞培养和复制得到了改善。血淋巴对多角体的合成有积极影响,并增强了草地贪夜蛾(Sf9)细胞(TCID50/mL)中的杆状病毒复制,从而改善了 Sf9 细胞培养。当细胞感染感染复数为 1 时,Grace 培养基中补充 10%(v/v)FBS 和 1%(v/v)血淋巴可增加杆状病毒的复制,此时杆状病毒的复制比对照(Grace 培养基中补充 10%(v/v)FBS)增加了 6443.91 倍。此外,这项工作表明,南美大蚕蛾的血淋巴可能因其增加细胞活力和病毒复制能力而在生物技术中有有趣的应用。